Medications and Therapies

Video Library

  • Running time: 4 minutes 8 seconds

    Video Library

    Combination of Lipid-Lowering Agents Optimally Regulate LDL-C Levels: Insights from the SANTORINI Study

    Check out our latest animated video to learn more about the one-year follow-up of the SANTORINI study.

    View

  • Running time: 10 minutes 12 seconds

    Video Library

    International Lipid Expert Panel Position Paper (2024 Recommendations)

    In this video, Prof. Maciej Banach discusses the 2024 recommendations on the optimal use of LLT in established ASCVD and following ACS.

    View
View All Medications and Therapies Video Library

Infographics

  • Infographics

    Understanding the Role of Eicosanoids in Atherosclerosis, with a Focus on Icosapent Ethyl as a Therapeutic Option for Cardiovascular Disease

    Eicosanoids are lipid-based mediators which play crucial roles in the inflammatory response and the development of ASCVD. This infographic delves into the intricate involvement of eicosanoids in atherosclerosis and highlights how icosapent ethyl serves as a key therapeutic option to mitigate ASCVD risks.

    View
    • Please enable JavaScript in your browser to complete this form.

    Please complete the form below with your details to access this content.

  • Infographics

    Targeting Inflammation as a Therapeutic Strategy for Dyslipidaemia and Atherosclerotic Cardiovascular Disease

    This infographic details the role of inflammation in atherosclerotic cardiovascular disease (ASCVD), exploring the impact of inflammation on disease progression, the effectiveness of lipid-lowering therapies combined with anti-inflammatory treatments, and ongoing research on novel therapeutic strategies to manage and prevent ASCVD.

    View
View All Medications and Therapies Infographics

Articles

View All Medications and Therapies Articles

Case Studies

  • Case Studies

    August 2023

    Take this short quiz to test your knowledge on the recently published debate on dyslipidemias titled “Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers”.

    CLICK HERE TO VIEW THE DEBATE.

    Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275

    Take

  • Case Studies

    Quiz of the month – May 2023

    Take this short quiz to test your knowledge on some of the latest peer-reviewed published literature related to ASCVD and Lipidology.

    Take

  • Case Studies

    Case Study – December 2022

    Our patient case study specially curated for you by our Faculty Member, Prof. Samer Ellahham on concerns about statin associated Diabetes Mellitus.

    Case Study: RS is a 64-year-old Male having dyslipidemia.

     

    Vital parameters:

    BP 144/87 mm Hg

    Low-density lipoprotein cholesterol (LDL-C) 112 mg/dL

    High-density lipoprotein cholesterol (HDL-C) of 47 mg/dL

    Triglycerides 190 mg/dL

    (-) tobacco, (-) alcohol

    Body mass index (BMI) 33 kg/m2

     

    Medication:

    Valsartan 80 mg/d

     

    Family history:

    Father developed type 2 diabetes mellitus (T2DM) and ASCVD at age 58

     

    Labs:

    Fasting blood glucose 103 mg/dL

    HbA1C 5.8%

    Serum Creatinine 1.1 mg/dL

    Urinary analysis within normal limits

     

     

    RS reports that he is reluctant to take statins as they cause diabetes especially with his family history.

    Read More
View All Medications and Therapies Case Studies